✦ LIBER ✦
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia
✍ Scribed by Jorge Cortes; Hagop Kantarjian; Edward D. Ball; John DiPersio; Jonathan E. Kolitz; Hugo F. Fernandez; Mark Goodman; Gautam Borthakur; Maria R. Baer; Meir Wetzler
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 229 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.